Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

HODHBt SYNERGIZES WITH IL-15 TO ENHANCE THE CYTOTOXIC CAPACITY OF HIV-SPECIFIC CTL

By Jimmy He PharmD, DScApril 4, 2022

…responses were enhanced by treatment with HODHBt in combination with IL-15, relative to medium only as follows: (mean/mean) Gag – 6.8-fold (p=0.005), Pol – 6.8-fold (p=0.005), Nef – 12.8-fold (p…

IDENTIFICATION OF HIV BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES TARGETING MPER

By Jimmy He PharmD, DScMarch 3, 2023

…(mAbs) were isolated from a subtype B infected donor using two parallel Methods: high-throughput B-cell culture followed by microneutralization assays, and fluorescently labeled MPER peptide to capture antigen-specific B cells…

406 – HIV-Infection Does Not Generally Confer Higher Resistance to CTL-Mediated Lysis

By Jimmy He PharmD, DScMarch 20, 2025

…However, some studies have suggested that HIV-infection might confer some level of intrinsic resistance to CTL-mediated lysis through various mechanisms such as the upregulation of anti-apoptotic factors. Here, we show…

IMPACT OF COVID-19 INDUCED PROGRAM ADAPTATIONS ON HIV SUPPRESSION IN THREE COUNTRIES

By Jimmy He PharmD, DScMarch 3, 2023

Background: The pandemic response measures have had significant global economic and health impacts with transient reductions in HIV clinic attendance and self-reported anti-retroviral therapy (ART) adherence reported in prior studies….

EARLY ANTIRETROVIRAL THERAPY REDUCES BUT DOES NOT ELIMINATE HIV DNA IN BLOOD

By Jimmy He PharmD, DScApril 4, 2022

…AEHI, either with a study-provided integrase inhibitor-based regimen or another prescribed regimen. Fiebig stage at ART initiation was retroactively assigned by centralized testing and categorized per protocol as Group 1…

576 – Activation of Latent HIV-1 by Retinol Binding Protein 4

By Jimmy He PharmD, DScMarch 20, 2025

…endogenous compounds that reactivate latent HIV-1 proviruses, we screened a human hemofiltrate-derived peptide library containing essentially all the peptides and small proteins circulating in blood. To this purpose, we used J-Lat…

BURSTING MYTHS: PROGRAMMATIC SCALEUP OF ISONIAZID PREVENTIVE THERAPY, KENYA 2014-2016

By Enthusiast Inc MDMarch 6, 2018

…and PEPFAR work plans, meeting notes, reports, and analyzed MOH IPT uptake and treatment outcome data from January 2014 to December 2016 in MS Excel®. Treatment outcomes were defined as:…

Increasing PrEP Use Among Men Who Have Sex With Men, New York City, 2013-2015

By Enthusiast Inc MDFebruary 16, 2016

…PrEP uptake. Using data from routine behavioral surveillance among men who have sex with men (MSM), we examined recent trends and associations with PrEP use.  Data were derived from annual…

Virus-Host Interactions Revealed Through Proteomics

By Enthusiast Inc MDSeptember 29, 2014

…in the sera of individuals. The majority of antibody derived peptides will be identical and shared between many different antibodies. Here, current strategies for identifying antibody specific peptides are described….

HIV-1 Reactivation Increases Mitochondrial Priming of the Latent Reservoir

By Enthusiast Inc MDFebruary 27, 2015

…the presence or absence of anti(a)-CD3/anti(a)-CD28 beads, vorinostat (SAHA), panobinostat (PNB), or romidepsin (RMD). Dose-ranging studies were performed and, after treatment with a standardized panel of death peptides, BH3 profiles…

←1
23456789101112131415161718192021222324252627282930313233343536
…3738394041…
4243444546474849505152535455565758596061626364656667686970717273747576777879808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top